178 related articles for article (PubMed ID: 15694876)
21. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
[TBL] [Abstract][Full Text] [Related]
23. Lidocaine patch 5 for carpal tunnel syndrome: how it compares with injections: a pilot study.
Nalamachu S; Crockett RS; Mathur D
J Fam Pract; 2006 Mar; 55(3):209-14. PubMed ID: 16510054
[TBL] [Abstract][Full Text] [Related]
24. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
Bennett MI; Smith BH; Torrance N; Potter J
J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
[TBL] [Abstract][Full Text] [Related]
25. Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies.
Herrmann DN; Pannoni V; Barbano RL; Pennella-Vaughan J; Dworkin RH
Muscle Nerve; 2006 Jan; 33(1):42-8. PubMed ID: 16228968
[TBL] [Abstract][Full Text] [Related]
26. The dimensions of pain quality: factor analysis of the Pain Quality Assessment Scale.
Victor TW; Jensen MP; Gammaitoni AR; Gould EM; White RE; Galer BS
Clin J Pain; 2008; 24(6):550-5. PubMed ID: 18574365
[TBL] [Abstract][Full Text] [Related]
27. Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases.
Nayak S; Cunliffe M
Paediatr Anaesth; 2008 Jun; 18(6):554-8. PubMed ID: 18363625
[TBL] [Abstract][Full Text] [Related]
28. Validation of the Short-form McGill Pain Questionnaire-2 (SF-MPQ-2) in acute low back pain.
Dworkin RH; Turk DC; Trudeau JJ; Benson C; Biondi DM; Katz NP; Kim M
J Pain; 2015 Apr; 16(4):357-66. PubMed ID: 25640290
[TBL] [Abstract][Full Text] [Related]
29. [The use of lidocaine-coated plates (versatis) in the treatment of back pain].
Levin OS; Moseĭkin IA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):44-50. PubMed ID: 19156086
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of neuropathic pain among patients suffering from chronic low back pain in Saudi Arabia.
Hassan AE; Saleh HA; Baroudy YM; Abdul-Rahman KI; Najjar MW; Kazi MS; El-Gazar MA; Hafez MA; Abdullah MA; Abdul-Rahman YA; Youseif EA
Saudi Med J; 2004 Dec; 25(12):1986-90. PubMed ID: 15711681
[TBL] [Abstract][Full Text] [Related]
31. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy.
Herrmann DN; Barbano RL; Hart-Gouleau S; Pennella-Vaughan J; Dworkin RH
Pain Med; 2005; 6(5):379-84. PubMed ID: 16266359
[TBL] [Abstract][Full Text] [Related]
32. Pain quality predicts lidocaine analgesia among patients with suspected neuropathic pain.
Carroll IR; Younger JW; Mackey SC
Pain Med; 2010 Apr; 11(4):617-21. PubMed ID: 20210867
[TBL] [Abstract][Full Text] [Related]
33. The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury.
Kvarnström A; Karlsten R; Quiding H; Gordh T
Acta Anaesthesiol Scand; 2004 Apr; 48(4):498-506. PubMed ID: 15025615
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
Ranoux D; Attal N; Morain F; Bouhassira D
Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
[TBL] [Abstract][Full Text] [Related]
35. A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component.
Yousef AA; Al-deeb AE
Anaesthesia; 2013 Mar; 68(3):260-6. PubMed ID: 23384256
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study.
Gormsen L; Finnerup NB; Almqvist PM; Jensen TS
Anesth Analg; 2009 Apr; 108(4):1311-9. PubMed ID: 19299805
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of the sustained-release hydromorphone in neuropathic pain management: pooled analysis of three open-label studies.
Moulin DE; Richarz U; Wallace M; Jacobs A; Thipphawong J
J Pain Palliat Care Pharmacother; 2010 Sep; 24(3):200-12. PubMed ID: 20718640
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy with flupirtine and opioid: open-label case series in the treatment of neuropathic pain associated with cancer.
Goodchild CS; Nelson J; Cooke I; Ashby M; Jackson K
Pain Med; 2008 Oct; 9(7):939-49. PubMed ID: 18950447
[TBL] [Abstract][Full Text] [Related]
39. Distinguishing between nociceptive and neuropathic components in chronic low back pain using behavioural evaluation and sensory examination.
Spahr N; Hodkinson D; Jolly K; Williams S; Howard M; Thacker M
Musculoskelet Sci Pract; 2017 Feb; 27():40-48. PubMed ID: 28637600
[TBL] [Abstract][Full Text] [Related]
40. 5% lidocaine medicated plaster use in children with neuropathic pain from burn sequelae.
Orellana Silva M; Yañez V; Hidalgo G; Valenzuela F; Saavedra R
Pain Med; 2013 Mar; 14(3):422-9. PubMed ID: 23279572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
